Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Nasdaq Notification Regarding Minimum Bid Price Deficiency
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Hideawayon Jul 11, 2022 1:48pm
197 Views
Post# 34815672

RE:Nasdaq Notification Regarding Minimum Bid Price Deficiency

RE:Nasdaq Notification Regarding Minimum Bid Price DeficiencyThe Nasdaq notification along with market events are having quite an effect on sp.According to chart from presentation,not much big news in works until possibly year's end.
Let's Hope something is announced soon as we have the summer months to get thru and if current trend continues,we will go lower.
Anybody have comments?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities